Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39

1.

The factor VIII:C/VWF:Ag ratio as a useful tool to predict relapse in patients with acquired haemophilia A: A retrospective cohort study.

Trossaert M, Graveleau J, Thiercelin-Legrand MF, Sigaud M, Guerrero F, Neel A, Fouassier M, Sailler L, Chauveau D, Ternisien C, Huart A, Gillet B, Hamidou M, Bene MC, Voisin S.

Haemophilia. 2019 May;25(3):527-534. doi: 10.1111/hae.13752. Epub 2019 May 2.

PMID:
31050100
2.

The challenge of myeloma-related thromboembolic disease: can thrombin generation assay help physicians to better predict the thromboembolic risk and personalize anti-thrombotic prophylaxis?

Dargaud Y, Fouassier M, Bordet JC, Ducastelle-Lepretre S, Dumontet C, Moreau P, Michallet M.

Leuk Lymphoma. 2019 Apr 3:1-4. doi: 10.1080/10428194.2019.1585839. [Epub ahead of print] No abstract available.

PMID:
30942646
3.

A new case of heterozygous variant of the GP1BB gene responsible for macrothrombocytopenia.

Babuty A, Boisseau P, Eveillard M, Ternisien C, Debord C, Sigaud M, Giraud M, Gillet B, Trossaert M, Béné MC, Fouassier M.

Br J Haematol. 2019 Jan 4. doi: 10.1111/bjh.15739. [Epub ahead of print] No abstract available.

PMID:
30609015
4.

Multidisciplinary Clinical Management of a Localized Aggressive Periodontitis diagnosed in a Child with Glanzmann's Thrombasthenia.

Prud'homme T, Roy E, Soueidan A, Fouassier M, Dajean-Trutaud S, Badran Z.

Int J Clin Pediatr Dent. 2018 Jul-Aug;11(4):344-348. doi: 10.5005/jp-journals-10005-1536. Epub 2018 Aug 1.

5.

Bleeding risk for patients with haemophilia under antithrombotic therapy. Results of the French multicentric study ERHEA.

Desjonqueres A, Guillet B, Beurrier P, Pan-Petesch B, Ardillon L, Pineau-Vincent F, Sigaud M, Fouassier M, Ternisien C, Gillet B, Béné MC, Horvais V, Lienhart A, Trossaërt M.

Br J Haematol. 2019 May;185(4):764-767. doi: 10.1111/bjh.15606. Epub 2018 Oct 18. No abstract available.

PMID:
30338508
6.

Two novel variants of uncertain significance in GP9 associated with Bernard-Soulier syndrome: Are they true mutations?

Boisseau P, Debord C, Eveillard M, Quéméner A, Sigaud M, Giraud M, Talarmain P, Thomas C, Landeau G, Bezieau S, Petesch BP, Béné MC, Fouassier M.

Platelets. 2018 May;29(3):316-318. doi: 10.1080/09537104.2017.1371288. Epub 2017 Nov 9.

PMID:
29119855
7.

Giant granule and platelets...

Eveillard M, Fouassier M.

Blood. 2017 Jun 1;129(22):3043. doi: 10.1182/blood-2017-02-767426. No abstract available.

8.

Bleeding risk of surgery and its prevention in patients with inherited platelet disorders.

Orsini S, Noris P, Bury L, Heller PG, Santoro C, Kadir RA, Butta NC, Falcinelli E, Cid AR, Fabris F, Fouassier M, Miyazaki K, Lozano ML, Zúñiga P, Flaujac C, Podda GM, Bermejo N, Favier R, Henskens Y, De Maistre E, De Candia E, Mumford AD, Ozdemir GN, Eker I, Nurden P, Bayart S, Lambert MP, Bussel J, Zieger B, Tosetto A, Melazzini F, Glembotsky AC, Pecci A, Cattaneo M, Schlegel N, Gresele P; European Hematology Association - Scientific Working Group (EHA-SWG) on thrombocytopenias and platelet function disorders.

Haematologica. 2017 Jul;102(7):1192-1203. doi: 10.3324/haematol.2016.160754. Epub 2017 Apr 6.

9.

Use of a thrombopoietin receptor agonist in von Willebrand disease type 2B (p.V1316M) with severe thrombocytopenia and intracranial hemorrhage.

Espitia O, Ternisien C, Agard C, Boisseau P, Denis CV, Fouassier M.

Platelets. 2017 Jul;28(5):518-520. doi: 10.1080/09537104.2016.1246717. Epub 2016 Nov 25.

PMID:
27885890
10.

A new mutation of ANO6 in two familial cases of Scott syndrome.

Boisseau P, Bene MC, Besnard T, Pachchek S, Giraud M, Talarmain P, Robillard N, Gourlaouen MA, Bezieau S, Fouassier M.

Br J Haematol. 2018 Mar;180(5):750-752. doi: 10.1111/bjh.14439. Epub 2016 Nov 23. No abstract available.

PMID:
27879994
11.

Flow cytometry in hematological nonmalignant disorders.

Béné MC, Le Bris Y, Robillard N, Wuillème S, Fouassier M, Eveillard M.

Int J Lab Hematol. 2016 Feb;38(1):5-16. doi: 10.1111/ijlh.12438. Epub 2015 Nov 6. Review.

PMID:
26542092
12.

Thrombin Generation Assay in Hospitalized Nonsurgical Patients: A New Tool to Assess Venous Thromboembolism Risk?

Espitia O, Fouassier M, Hardouin JB, Pistorius MA, Agard C, Planchon B, Trossaert M, Pottier P.

Clin Appl Thromb Hemost. 2017 Jan;23(1):45-51. Epub 2015 Aug 9.

PMID:
26259913
13.

[Thrombin generation test].

Espitia O, Fouassier M.

Rev Med Interne. 2015 Oct;36(10):690-3. doi: 10.1016/j.revmed.2015.04.013. Epub 2015 May 28. French.

PMID:
26028157
14.

Detection of phosphatidyl serine on activated platelets' surface by flow cytometry in whole blood: a simpler test for the diagnosis of Scott syndrome.

Halliez M, Fouassier M, Robillard N, Ternisien C, Sigaud M, Trossaert M, Bene MC.

Br J Haematol. 2015 Oct;171(2):290-292. doi: 10.1111/bjh.13391. Epub 2015 Mar 31. No abstract available.

PMID:
25823976
15.

Platelet function analyser (PFA-100) results and von Willebrand factor deficiency: a 16-year 'real-world' experience.

Ardillon L, Ternisien C, Fouassier M, Sigaud M, Lefrançois A, Pacault M, Ribeyrol O, Fressinaud E, Boisseau P, Trossaërt M.

Haemophilia. 2015 Sep;21(5):646-52. doi: 10.1111/hae.12653. Epub 2015 Mar 10.

PMID:
25753785
16.

An unexpected etiology of priapism: infection-related anti-protein s antibodies.

Boissier E, Durant C, Vildy S, Glemain P, Lakhal K, Graveleau J, Masseau A, Fouassier M.

J Sex Med. 2014 Nov;11(11):2830-3. doi: 10.1111/jsm.12660. Epub 2014 Aug 8.

PMID:
25104179
17.

Management of bleeding in severe factor V deficiency with a factor V inhibitor.

Ardillon L, Lefrançois A, Graveleau J, Fouassier M, Ternisien C, Sigaud M, Fretigny M, Archambeaud I, Trossaërt M.

Vox Sang. 2014 Jul;107(1):97-9. doi: 10.1111/vox.12134. Epub 2014 Feb 12.

PMID:
24517203
18.

Diagnosis and management challenges in patients with mild haemophilia A and discrepant FVIII measurements.

Trossaert M, Lienhart A, Nougier C, Fretigny M, Sigaud M, Meunier S, Fouassier M, Ternisien C, Negrier C, Dargaud Y.

Haemophilia. 2014 Jul;20(4):550-8. doi: 10.1111/hae.12381. Epub 2014 Feb 12.

PMID:
24517184
19.

[Acquired hemophilia A. A monocentric retrospective study of 39 patients].

Graveleau J, Trossaërt M, Leux C, Masseau A, Ternisien C, Néel A, Fouassier M, Agard C, Sigaud M, Hamidou M.

Rev Med Interne. 2013 Jan;34(1):4-11. doi: 10.1016/j.revmed.2012.10.367. Epub 2012 Dec 14. French.

PMID:
23246283
20.

An unexpected transmission of von Willebrand disease type 3: the first case of maternal uniparental disomy 12.

Boisseau P, Giraud M, Ternisien C, Veyradier A, Fressinaud E, Lefrancois A, Bezieau S, Fouassier M.

Haematologica. 2011 Oct;96(10):1567-8. doi: 10.3324/haematol.2010.036897. Epub 2011 Jul 12. No abstract available.

21.

Thrombocytopenia-absent radius (TAR) syndrome: a clinical genetic series of 14 further cases. impact of the associated 1q21.1 deletion on the genetic counselling.

Houeijeh A, Andrieux J, Saugier-Veber P, David A, Goldenberg A, Bonneau D, Fouassier M, Journel H, Martinovic J, Escande F, Devisme L, Bisiaux S, Chaffiotte C, Baux M, Kerckaert JP, Holder-Espinasse M, Manouvrier-Hanu S.

Eur J Med Genet. 2011 Sep-Oct;54(5):e471-7. doi: 10.1016/j.ejmg.2011.05.001. Epub 2011 May 13.

PMID:
21635976
22.

Prevalence, biological phenotype and genotype in moderate/mild hemophilia A with discrepancy between one-stage and chromogenic factor VIII activity.

Trossaërt M, Boisseau P, Quemener A, Sigaud M, Fouassier M, Ternisien C, Lefrançois-Bettembourg A, Tesson C, Thomas C, Bezieau S.

J Thromb Haemost. 2011 Mar;9(3):524-30. doi: 10.1111/j.1538-7836.2010.04174.x.

23.

Evaluation of an automated von Willebrand factor activity assay in von Willebrand disease.

Trossaërt M, Ternisien C, Lefrancois A, Llopis L, Goudemand J, Sigaud M, Fouassier M, Caron C.

Clin Appl Thromb Hemost. 2011 Nov-Dec;17(6):E25-9. doi: 10.1177/1076029610379848. Epub 2010 Aug 19.

PMID:
20724302
24.

Factor VIII-von Willebrand factor complex inhibits osteoclastogenesis and controls cell survival.

Baud'huin M, Duplomb L, Téletchéa S, Charrier C, Maillasson M, Fouassier M, Heymann D.

J Biol Chem. 2009 Nov 13;284(46):31704-13. doi: 10.1074/jbc.M109.030312. Epub 2009 Sep 16.

25.

Increase in proinflammatory cytokines in peripheral blood without haemostatic changes after LPS inhalation.

Fouassier M, Souweine B, Sapin AF, Hashemzadeh A, Marquès-Verdier A, Caillaud D.

Thromb Res. 2009 Nov;124(5):584-7. doi: 10.1016/j.thromres.2009.06.014. Epub 2009 Jul 23.

PMID:
19631363
26.

Absence of JAK2-V617F in paroxysmal nocturnal haemoglobinuria-associated thrombosis.

Fouassier M, Girodon F, Cleyrat C, Robillard N, Garand R, Hermouet S.

Thromb Haemost. 2009 Jul;102(1):180-2. doi: 10.1160/TH09-03-0140. No abstract available.

PMID:
19572087
27.

Hyperzincemia and hypercalprotectinemia: unsuccessful treatment with tacrolimus.

Isidor B, Poignant S, Corradini N, Fouassier M, Quartier P, Roth J, Picherot G.

Acta Paediatr. 2009 Feb;98(2):410-2. doi: 10.1111/j.1651-2227.2008.01092.x. Epub 2008 Nov 4.

PMID:
18983438
28.

D-dimers, thrombin-antithrombin complexes, and risk factors for thromboembolism in hospitalized patient.

Pottier P, Fouassier M, Hardouin JB, Volteau C, Planchon B.

Clin Appl Thromb Hemost. 2009 Dec;15(6):666-75. doi: 10.1177/1076029608321436. Epub 2008 Sep 15.

PMID:
18796458
29.

Prospective evaluation of the '4Ts' score and particle gel immunoassay specific to heparin/PF4 for the diagnosis of heparin-induced thrombocytopenia.

Pouplard C, Gueret P, Fouassier M, Ternisien C, Trossaert M, Régina S, Gruel Y.

J Thromb Haemost. 2007 Jul;5(7):1373-9. Epub 2007 Mar 14.

30.

Latent myeloproliferative disorder revealed by the JAK2-V617F mutation and endogenous megakaryocytic colonies in patients with splanchnic vein thrombosis.

Boissinot M, Lippert E, Girodon F, Dobo I, Fouassier M, Masliah C, Praloran V, Hermouet S.

Blood. 2006 Nov 1;108(9):3223-4. No abstract available.

31.

Evolution of thrombin formation and fibrinolysis markers, including thrombin-activatable fibrinolysis inhibitor, during severe meningococcemia.

Fouassier M, Moreau D, Thiollière F, Frère C, Marquès-Verdier A, Souweine B.

Pathophysiol Haemost Thromb. 2005;34(6):284-7.

32.

Molecular bases of antithrombin deficiency: twenty-two novel mutations in the antithrombin gene.

Picard V, Nowak-Göttl U, Biron-Andreani C, Fouassier M, Frere C, Goualt-Heilman M, de Maistre E, Regina S, Rugeri L, Ternisien C, Trichet C, Vergnes C, Aiach M, Alhenc-Gelas M.

Hum Mutat. 2006 Jun;27(6):600. Erratum in: Hum Mutat. 2006 Nov;27(11):1160.

PMID:
16705712
33.

Determination of serotonin release from platelets by HPLC and ELISA in the diagnosis of heparin-induced thrombocytopenia: comparison with reference method by [C]-serotonin release assay.

Fouassier M, Bourgerette E, Libert F, Pouplard C, Marques-Verdier A.

J Thromb Haemost. 2006 May;4(5):1136-9. No abstract available.

34.

Normal human bone marrow CD34(+)CD133(+) cells contain primitive cells able to produce different categories of colony-forming unit megakaryocytes in vitro.

Charrier S, Boiret N, Fouassier M, Berger J, Rapatel C, Pigeon P, Mareynat G, Bonhomme J, Camilleri L, Berger MG.

Exp Hematol. 2002 Sep;30(9):1051-60.

PMID:
12225797
35.

CFU-Mk content of immunoselected CD34+ peripheral blood progenitor cells, evaluated with an adapted serum-free methylcellulose assay, is predictive of platelet lineage reconstitution in children with solid tumors.

Boiret N, Kanold J, Fouassier M, Bons JM, Halle P, Rapatel C, Berger J, Pireyre P, Blanzat V, Travade P, Bonhomme J, Demeocq F, Berger MG.

J Hematother Stem Cell Res. 2000 Aug;9(4):525-34.

PMID:
10982252
36.

[Geotrichum capitatum infection in a neutropenic patient. Apropos of a case and review of the literature].

Fouassier M, Joly D, Cambon M, Peigue-Lafeuille H, Condat P.

Rev Med Interne. 1998 Jun;19(6):431-3. Review. French.

PMID:
9775185
37.

Bilateral eyelid localisation of a lymphoplasmacytoid lymphoma.

Fouassier M, Menerath JM, Tavernier F, Fouilhoux A, Kemeny JL, Rozan R, Travade P.

Leuk Lymphoma. 1997 Oct;27(3-4):369-71.

PMID:
9402336
38.

Autoimmune thrombocytopenia after six cycles of fludarabine phosphate in a patient with chronic lymphocytic leukemia.

Bay JO, Fouassier M, Béal D, Alcaraz L, Cure H, Chollet P, Plagne R, Travade P.

Hematol Cell Ther. 1997 Aug;39(4):209-12.

PMID:
9352330
39.

Supplemental Content

Loading ...
Support Center